3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Hip Fractures
1
Glioma
1
Glioblastoma
1
Fractures, Spontaneous
1
Financial Stress
1
Dysplastic Nevus Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
COVID-19
1
Breast Neoplasms
1
Brain Neoplasms
1
Bone Neoplasms
1
Ataxia Telangiectasia
1
Interventions
pirtobrutinib
3
Cyclophosphamide
3
Azacitidine
3
ibrutinib
2
fludarabine
2
Mycophenolic Acid
2
Lenalidomide
2
zanubrutinib
1
venetoclax
1
ruxolitinib
1
ponatinib
1
nilotinib
1
idelalisib
1
idecabtagene vicleucel
1
fludarabine phosphate
1
cedazuridine
1
cc-486
1
asciminib
1
acalabrutinib
1
Whole-Body Irradiation
1
Vancomycin
1
Tretinoin
1
Tacrolimus
1
Sirolimus
1
Semen Analysis
1
Rituximab
1
Quality of Life
1
Physical Examination
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
Data Collection
×
90 days
×
Clear all
No trials found.